HIV-1-infection Completed Phase 2 Trials for Maraviroc (DB04835)

Also known as: HIV -1 Infection / HIV1 Infection / HIV-I Infection / HIV 1 Infection / Human Immunodeficiency Virus Type 1 (HIV-1) Infection / Human Immunodeficiency Virus I Infection / Infection, Human Immunodeficiency Virus I / HIV-1 Infections / HIV-1 Infection / [X]Human immunodeficiency virus disease (disorder) / Human immunodeficiency virus [HIV] disease / [X]Unspecified human immunodeficiency virus [HIV] disease (disorder) / HIV disease / (AIDS) or (HIV infection) / HTLV-III/LAV infection -RETIRED- / HIV infection NOS / Human immunodeficiency virus syndrome / Human immunodeficiency virus infection, unspecified / HIV Infections / HIV infection / Human immunodeficiency virus infection (disorder)

IndicationStatusPhase
DBCOND0054009 (HIV-1-infection)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01400412Bone, Immunologic, and Virologic Effects of a Antiretroviral RegimenTreatment
NCT00993148Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1Treatment